Plain-English translation of NCT07407231 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a two-step treatment approach for pancreatic cancer that cannot be removed with surgery. First, you would receive standard chemotherapy drugs. Then, if your cancer hasn't worsened, you would receive a specialized form of radiation called SBRT (stereotactic body radiotherapy), which delivers a high dose of radiation precisely to the tumor while protecting nearby organs.
Pancreatic cancer is very aggressive and often spreads even after chemotherapy. This trial exists because doctors want to see if adding this focused, high-dose radiation after chemotherapy can better control the cancer in its original location and improve survival, while keeping side effects manageable.
You likely qualify if…
You likely don't qualify if…
You would first receive standard chemotherapy according to your doctor's treatment plan at a participating medical center. After completing this chemotherapy, if your cancer hasn't worsened, you would undergo the specialized radiation treatment (SBRT) directed at your pancreatic tumor, which is typically delivered over several sessions. After the radiation is complete, you may continue with additional chemotherapy based on your doctor's clinical judgment. The study will monitor how well the treatment works and track any side effects you experience.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Slovenia